Suchergebnisse - "Meissner, H Cody"

PubPharm (7)

1

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis

enthalten in: Pediatrics | 2011

von Weisman, L. | Thackray, H. | Steinhorn, R. | +14

2

The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus

enthalten in: Pediatrics | 2009

von Meissner, H. | Bocchini, J. | Brady, M. | +3

3

From the American Academy of Pediatrics : Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections

enthalten in: Pediatrics | 2009

von Committee on Infectious Diseases | Bocchini, J. | Bernstein, H. | +31

CommentIn: Pediatrics. 2010 Apr;125(4):e1021; author reply e1022. - PMID 20360416

4

Annual variation in respiratory syncytial virus season and decisions regarding immunoprophylaxis with palivizumab

enthalten in: Pediatrics | 2004

von Meissner, H. | Anderson, L. | Pickering, L.

CommentOn: Pediatrics. 1998 Sep;102(3 Pt 1):531-7. - PMID 9738173

5

Risk of severe respiratory syncytial virus disease, identification of high risk infants and recommendations for prophylaxis with palivizumab

enthalten in: The Pediatric infectious disease journal | 2004

von Meissner, H. | Rennels, M. | Pickering, L. | +1

CommentOn: Pediatr Infect Dis J. 2003 Nov;22(11):939-43. - PMID 14614363

6

Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections

enthalten in: Pediatrics | 2003

von Meissner, H. | Long, S. | American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

7

Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease

enthalten in: The Journal of pediatrics | 2003

von Feltes, T. | Cabalka, A. | Meissner, H. | +6

CommentIn: J Pediatr. 2004 Jun;144(6):837. - PMID 15212065

1
[1]